1. Home
  2. CPHI

CPHI

China Pharma Holdings Inc.

Logo China Pharma Holdings Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 11:32am EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Founded: N/A Country:
China
China
Employees: N/A City: HAINAN PROVINCE
Market Cap: 5.5M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 367.8K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.91 EPS Growth: N/A
52 Week Low/High: $0.32 - $2.70 Next Earning Date: 05-10-2024
Revenue: $7,011,299 Revenue Growth: -13.48%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: